Cell-Free DNA Release by Mouse Fetal Membranes

• Published in: Reproductive sciences (Thousand Oaks, Calif.) Calif.), 2019-06, Vol.26 (6), p.847-857
• Main Authors: Sawyer, Michala R., Adeli, Sharareh, Phillippe, Mark
• Format: Article
• Language: English
• Subjects: 5-Methylcytosine - analysis; Amino Acid Chloromethyl Ketones - pharmacology; Animals; Apoptosis - drug effects; Caspase Inhibitors - pharmacology; Cell-Free Nucleic Acids - isolation & purification; Cell-Free Nucleic Acids - metabolism; Culture Media, Conditioned - chemistry; Embryology; Extraembryonic Membranes - chemistry; Extraembryonic Membranes - metabolism; Female; Medicine & Public Health; Mice; Obstetrics/Perinatology/Midwifery; Original Article; Placenta - chemistry; Pregnancy; Quinolines - pharmacology; Reproductive Medicine; Signal Transduction - drug effects; Thapsigargin - pharmacology
• ISSN: 1933-7191; 1933-7205
• DOI: 10.1177/1933719118817659

Introduction: Cell-free “fetal” DNA is released from the placenta. Because the fetal membranes also arise from the trophectoderm layer of the blastocyst, these studies sought to test the hypothesis that the membranes also release cell-free DNA (cfDNA). Methods: Fetal membranes were harvested from pregnant CD-1 mice and cultured in 12-well plates containing media alone or with staurosporine and thapsigargin (apoptosis stimulators), Q-VD-OPh (caspase inhibitor), Trolox (vitamin E analog), and lipopolysaccharide and tumor necrosis factor α (TNFα; inflammatory mediators). The cfDNA in the media was extracted, quantified, and normalized for tissue weight. Media was used for a lactate dehydrogenase (LDH) assay. Membrane homogenates were used to assess activated caspase levels and the expression of DNA fragmentation factor B (DFFB) and BAX proteins. 5-Methylcytosine was assessed using a 5-mC DNA enzyme-linked immunosorbent assay. The cfDNA was used to stimulate interleukin 6 (IL6) release by J774A.1 mouse macrophage cells. Results: Increased cfDNA release at 6 and 21 hours occurred in parallel with increasing LDH levels. The cfDNA concentrations were significantly suppressed by Q-VD-OPh and Trolox and increased by thapsigargin and TNFα. Increased caspase activity was suppressed by Q-VD-OPh and increased by TNFα, thapsigargin, and staurosporine. The expression of BAX and DFFB proteins significantly increased by 21 hours. 5-Methylcytosine levels were significantly lower in fetal membranes and placentas and below detectable in the cfDNA released by the explants. The cfDNA-stimulated IL6 release by macrophage cells was suppressed by chloroquine, a Toll-like receptor 9 (TLR9) inhibitor. Conclusions: These studies have confirmed cfDNA release by the mouse fetal membranes; cfDNA was markedly hypomethylated and a robust stimulator of TLR9.